NASDAQ:ARDS

Aridis Pharmaceuticals Stock Signals

etoro logo Buy ARDS
*Your capital is at risk
$0.0001
+0 (+0%)
At Close: Jul 31, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Aridis Pharmaceuticals Inc.

General

Signal Type Signal Value Data
Score 0.000 109 days ( 50.00 %
Last Price $0.0001 0 %
Performance History
7 Days
$0.0004 $0.0001
-75.00%
30 Days
$0.0004 $0.0001
-75.00%
12 Mos
$0.0001 $0.0001
0%

5/18

Active Buy Signals

Specific Signals

Short Term
Net score: 25
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0001 - $0.0001
Trend - 3 mos -45.85 % High Width: 245.62 %
Pred. range - 3 mos N/A - $0.0012 Low -100.00 % - 1,093.57 %
Volume Direction Sell High Volume: 13 · Direction: 0
Pivot Short Buy Very Low Jul 27, 2026 - 5 days
RSI Short Pivot Signal Sell Very Low Jul 10, 2026 - 16 days
Short MA 3 mos Sell Low Jun 24, 2026 - 27 days
Long MA 3 mos Sell Medium Jun 24, 2026 - 27 days
Short/Long MA 3 mos Buy Medium Jun 29, 2026 - 24 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 37.4
Signal Type Signal Value Importance Data
Trend - 12 mos 12.46 % Very High Width: 1,402.19 %
Pred. range - 12 mos N/A - $0.0035 High -100.00 % - 3,418.81 %
Short MA 12 mos Sell Very High Jun 24, 2026 - 27 days
Long MA 12 mos Sell Very High Jun 24, 2026 - 27 days
Short/Long MA 12 mos Sell Very High Jul 21, 2026 - 9 days
Pivot Long Buy Low Jul 27, 2026 - 5 days
RSI Long Pivot Signal Sell Low Jul 21, 2026 - 9 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Buy High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT ARIDIS PHARMACEUTICALS INC.
Aridis Pharmaceuticals
Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin. The company is also developing AR-32...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE